KPRX - KIORA PHARMACEUTICALS INC

1.98
-0.050   -2.525%

Share volume: 36,272
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$2.03
-0.05
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 35%
Dept financing 25%
Liquidity 50%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.88%
1 Month
-10.81%
3 Months
-4.35%
6 Months
-26.32%
1 Year
-39.08%
2 Year
-66.94%
Key data
Stock price
$1.98
P/E Ratio 
0.00
DAY RANGE
$1.96 - $2.01
EPS 
-$2.14
52 WEEK RANGE
$1.76 - $4.18
52 WEEK CHANGE
-$37.93
MARKET CAP 
9.545 M
YIELD 
N/A
SHARES OUTSTANDING 
3.678 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-09-2025
BETA 
1.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$23,780
AVERAGE 30 VOLUME 
$37,156
Company detail
CEO: Brian M. Strem
Region: US
Website: kiorapharma.com
Employees: 10
IPO year: 2015
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Kiora Pharmaceuticals, Inc. develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases.

Recent news